Searchable abstracts of presentations at key conferences in endocrinology

ea0029p53 | Adrenal cortex | ICEECE2012

Relationship of current glucocorticoid dose with metabolic outcomes in CAH: analysis of the United Kingdom congenital adrenal hyperplasia adult study executive (CaHASE) cohort

Han T. , Stimson R. , Rees A. , Krone N. , Willis D. , Wild S. , Conway G. , Arlt W. , Walker B. , Ross R. , CaHASE X.

We have previously reported the following metabolic abnormalities were common in 203 adult patients with CAH: obesity (41%), hypercholesterolemia (46%), insulin resistance (29%), osteopenia (40%) and osteoporosis (7%) (Arlt et al. JCEM 2010 95 5110–21). The CAH patients were taking different glucocorticoid therapies at various doses (n=196): hydrocortisone (n=25 M, 26 W), prednisolone (n=21M,67W), dexamethasone (n=15M,22W) or comb...